Premium HealthCare UK Ezetimibe 10mg is a selective cholesterol absorption inhibitor studied for lipid management and cardiovascular risk reduction research.
Key Details
– 100 tablets x 10mg
– Oral administration
Research Benefits
– Selectively inhibits intestinal absorption of dietary and biliary cholesterol
– Studied for LDL-C reduction as monotherapy and combination therapy
– Cardiovascular risk reduction research with statin combination
– Well-tolerated lipid-lowering mechanism distinct from statins
– Research applications in familial hypercholesterolaemia models
Suggested Research Protocol
– Dose: 10mg once daily oral
Quality Assurance: Pharmaceutical grade, batch verified.
Reviews
There are no reviews yet.